APH.TO - Aphria Inc.

Toronto - Toronto Delayed Price. Currency in CAD
15.15
-0.55 (-3.50%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close15.70
Open15.85
Bid15.10 x 0
Ask15.17 x 0
Day's Range14.65 - 16.64
52 Week Range8.62 - 24.75
Volume12,851,874
Avg. Volume12,439,748
Market Cap3.784B
Beta (3Y Monthly)3.96
PE Ratio (TTM)84.17
EPS (TTM)0.18
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.56
  • The Canadian Press4 days ago

    Most actively traded companies on the TSX

    Some of the most active companies traded Friday on the Toronto Stock Exchange:

  • Pot firm Canopy's loss widens as spending surges, shares fall
    Reuters27 days ago

    Pot firm Canopy's loss widens as spending surges, shares fall

    Marijuana companies in Canada have been pouring cash into their businesses to both fend off competition and open stores as the list of medical and recreational approvals for marijuana use globally grows. In the reported quarter, Canopy's operating expenses rose more than six times to C$180.6 million from C$27.7 million a year earlier. Canopy has the money after drawing a multi-billion dollar investment from Corona beer maker Constellation Brands in August, a reflection of investors betting broader legalization in the United States may also be in the pipeline.

  • ACCESSWIRElast month

    Marijuana Stocks Rally Into Thursday Morning After Sessions News: Integrated Cannabis Company (OTC: ICNAF) (CSE: ICAN), Aphria, Emerald Health

    CORAL GABLES, FL / ACCESSWIRE / November 8, 2018 / Marijuana stocks have seen a surge of attention this year. This event has been well received by the public markets as many marijuana stocks have positively reacted to this news. Sessions, who has been a staunch adversary of the legalization of cannabis, took a very conservative approach when broaching the subject.

  • The Canadian Presslast month

    Most actively traded companies on the TSX

    Some of the most active companies traded Wednesday on the Toronto Stock Exchange:

  • Newsfilelast month

    Rapid Dose Therapeutics Signs an Exclusive Preferred Global Vendor Agreement with Aphria

    Toronto, Burlington, Ontario--(Newsfile Corp. - November 5, 2018) - ACME Resources Corp. ("ACME") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that RDT and Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) have signed a definitive agreement granting Aphria exclusive preferred global vendor status for the production and sales of RDT's QuickStrip™ technology for both medicinal and adult-use cannabis markets around the world. RDT's game-changing, proprietary QuickStrip™ technology is a Quick, ...

  • ACCESSWIRElast month

    Investors Eyeing New Trends in Biopharma & Healthcare: Stocks Heading Higher

    CORAL GABLES, FL / ACCESSWIRE / November 2, 2018 / The recent boom for things like medical marijuana in the UK as well as the rise of healthcare technology have investors interested in new and exciting companies. Recent developments across both sectors have new companies targeting expanded market share. Technology has become a major part of the healthcare industry, as we know it.

  • Supply Shortages, Regulatory Hurdles to Keep Marijuana Stocks Depressed
    The Motley Foollast month

    Supply Shortages, Regulatory Hurdles to Keep Marijuana Stocks Depressed

    Marijuana stocks, such as Aphria Inc. (TSX:APH), are under threat from supply shortages and regulatory hurdles.

  • Aphria's Australian-Based Partner Althea Granted Manufacture Licence
    CNW Grouplast month

    Aphria's Australian-Based Partner Althea Granted Manufacture Licence

    LEAMINGTON, ON, Nov. 1, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Australian-based partner Althea Company Pty Ltd. ("Althea" or the "Australian Company") has been granted a Manufacture Licence by the Australian Government's Office of Drug Control. The license provides Althea with authorization to manufacture extracts and tinctures of cannabis and cannabis resin in accordance with relevant manufacture permits. "We are excited to see our Australian partner achieve yet another milestone in receiving its Manufacture License.

  • Why Investors Should Always Do Their Own Research Before Buying Stocks
    The Motley Foollast month

    Why Investors Should Always Do Their Own Research Before Buying Stocks

    Shopify Inc (TSX:SHOP)(NYSE:SHOP) saw its share price take a big hit last year after a biased report sent investors into a panic.

  • ACCESSWIRElast month

    Today's Research Reports on GeneNews, Medicure, Aphria and Resverlogix

    NEW YORK, NY / ACCESSWIRE / November 1, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • Is it Time to Buy Marijuana Stocks Like Canopy Growth Corp (TSX:WEED)?
    The Motley Foollast month

    Is it Time to Buy Marijuana Stocks Like Canopy Growth Corp (TSX:WEED)?

    Canopy Growth Corp. (TSX:WEED)(NYSE:CGC), Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB), and Aphria Inc. (TSX:APH) are all still trading in bubble territory. Investors had best be patient and wait for the right time to invest; it will come.

  • ACCESSWIRElast month

    3 Marijuana Stocks Looking Toward A Market Turnaround

    Leading up to the October 17th "legalization date" in Canada, investors saw a surge in cannabis stock interest. Canadian producers and retailers have been unable to keep up with the demand among consumers for cannabis products. With this in mind, we look at 3 marijuana stocks to watch as legalization continues to reach across North America.

  • Aphria to commence trading on the NYSE on November 2
    CNW Grouplast month

    Aphria to commence trading on the NYSE on November 2

    LEAMINGTON, ON, Oct. 30, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH) and (US OTC: APHQF) announced today that its common shares have been approved for listing on the New York Stock Exchange ("NYSE") and will commence trading effective the open of markets on November 2, 2018.

  • Baystreetlast month

    Leading Top 5 California Edibles Brand Becomes Market’s Newest Cannabis IPO

    With two of the top 10 selling edible cannabis products in California under its banner, one of the ...

  • Earnings Season Is Here: 3 Things to Look for When Companies Report
    The Motley Foollast month

    Earnings Season Is Here: 3 Things to Look for When Companies Report

    Aphria Inc (TSX:APH) released its earnings earlier in the month, and there were some warning flags that investors may have missed.

  • Will Supply Issues Plague Cannabis Stocks for the Rest of 2018?
    The Motley Foollast month

    Will Supply Issues Plague Cannabis Stocks for the Rest of 2018?

    Aphria Inc. (TSX:APH) and other cannabis stocks will be exposed to volatility as the industry struggles to meet soaring demand.

  • Can Aphria Inc (TSX:APH) Turn it Around With an NYSE Listing?
    The Motley Foollast month

    Can Aphria Inc (TSX:APH) Turn it Around With an NYSE Listing?

    Aphria Inc (TSX:APH) is about to list its shares on the New York Stock Exchange. Will it be enough to rescue the stock from the cannabis sell-off?

  • 3 Reasons Aphria Inc. (TSX:APH) Ought to Find a Partner
    The Motley Fool2 months ago

    3 Reasons Aphria Inc. (TSX:APH) Ought to Find a Partner

    Debt-rating agency DBRS Ltd. believes many of the cannabis producers will fail. It’s one of three reasons Aphria Inc. (TSX:APH) ought to find a partner.

  • Aphria Introduces Dr. Jonathan Simone, PhD as Director of Research and Clinical Studies
    CNW Group2 months ago

    Aphria Introduces Dr. Jonathan Simone, PhD as Director of Research and Clinical Studies

    LEAMINGTON, ON, Oct. 25, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today officially introduced Dr. Jonathan Simone, PhD as the Company's Director of Research and Clinical Studies. Dr. Simone joined Aphria in July 2018 and serves as the primary liaison between the Company's science, technical and medical division teams and outside medical, academic and clinical centers.

  • ACCESSWIRE2 months ago

    3 Marijuana Stocks Heading Higher After Breaking News

    CORAL GABLES, FL / ACCESSWIRE / October 25, 2018 / According to a new report by Grand View Research, Inc., the global legal marijuana market is expected to reach $146.4 billion by end of 2025. This week the market along with several cannabis stocks are looking to turn a corner and head back toward previous highs. Integrated Cannabis Company (ICNAF) (ICAN.CN) reported today that the marijuana company has agreed to license Cannabidiol-formulated gummies.

  • GlobeNewswire2 months ago

    Solar Energy and its future in the Cannabis Market; Aurora Cannabis, Solar Integrated Roofing Corporation (OTC: SIRC), Canadian Solar Inc., Aphria Inc.

    Investorideas.com, a global news source covering leading sectors including both cannabis and solar stocks, issues a snapshot looking at how solar energy has and will play a key role in the future of the cannabis sector. Companies mentioned: Aurora Cannabis Inc. (TSX: ACB.TO) (NYSE: ACB), Solar Integrated Roofing Corporation (OTC: SIRC), Canadian Solar Inc. (NASDAQ: CSIQ), Aphria Inc. (TSX: APH.TO), (OTC: APHQF), and Emerald Health Therapeutics, Inc.

  • A Guide to Surviving the Cannabis Sector Carnage
    The Motley Fool2 months ago

    A Guide to Surviving the Cannabis Sector Carnage

    Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) and other major cannabis stocks have been punished since legalization.